Business
Elast-Eon Improves Reliabilit
Elast-Eon Improves Reliabilit.
About this update from Rua Life Sciences Plc
[{"type":"text","content":"\n RNS Number : 2536Y Aortech International PLC 20 December 2010 \n \n\n\n\n\n\nFor Immediate Release\n\n\n20 December 2010\n\n\n\n\n \n \nAorTech Polymers Significantly Improve Reliability Performance for \nPacemaker Products\n \nIn an announcement made in the Wall Street Journal on 17 December 2010, St. Jude Medical reported that:\n \n\"The company told doctors that newer leads with a type of insulation it calls \"Optim™\" - sold with Riata ST Optim™ and Durata™ leads - have demonstrated a better than 80% reduction in \"abrasion-related observations\" after 44 months compared with silicone leads. The Optim™ insulation involves both silicone and polyurethane.\"\n \nSt. Jude Medical stated that it had converted 97% of its production to Optim™. Optim™ is the brand name used by St. Jude Medical for AorTech's polymer Elast-Eon™. AorTech markets the same material as Elast-Eon™. \n \nAorTech CEO Frank Maguire said, \"We are pleased that St. Jude Medical has published these clinical results that rest on the outstanding performance of our Elast-Eon™ polymers as well as our unique manufacturing process, which allow us to provide highly consistent materials delivered to our customers. This announcement on the part of St. Jude Medical is another important step forward in the commercialisation of AorTech polymers in a wide variety of implantable medical devices.\"\n\n \n-Ends-\n \nFor further information please contact:\n \nAorTech International plc\nFrank Maguire, Chief Executive\nTel: + 1 801 201 4336\n \nEvolution SecuritiesBobbie Hilliam / Chris Clarke\nTel: +44 20 7071 4300\n \nAorTech International plc\nSarah Price, Investor Relations\nTel: + 1 801 550 4349\ne-mail [email protected]\n\n\nAbout AorTech\n \nAorTech develops and manufactures biostable, implantable polymers, including Elast-Eon™ and ECSil™, the world's leading long-term implantable co-polymers. With more than 3 million implants and over four years of successful clinical use, AorTech polymers are currently used in cardiology, orthopaedic, urological and gastroenterological applications, including pacing leads, cardiac cannulae and stents. Devices manufactured from AorTech polymers have numerous US FDA PMA approvals, 510k's, CE Marks, Australian TGA and Japanese Ministry of Health ap...